A Modified Maze Versus Cut-and-Sew Maze for Long-Standing Persistent Atrial Fibrillation Concomitant with Mitral

Huishan Wang1, Jinsong Han1, Zengwei Wang1

  • 1Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China.

Insights

A modified maze procedure for atrial fibrillation (AF) reduces operating time compared to the standard cut-and-sew maze (CSM) while maintaining similar efficacy in preventing AF recurrence after mitral valve surgery.

Area of Science:

  • Cardiac Surgery
  • Electrophysiology
  • Minimally Invasive Procedures

Background:

  • The standard cut-and-sew maze (CSM) procedure effectively treats persistent atrial fibrillation (AF) during mitral valve surgery.
  • CSM's complexity and prolonged cardiopulmonary bypass times limit its widespread adoption.

Purpose of the Study:

  • To evaluate a modified maze procedure combining left atrial "cut-and-sew" with right atrial cryoablation and cavotricuspid isthmus ablation.
  • To compare the early operative outcomes and long-term efficacy of the modified maze with the standard CSM procedure.

Main Methods:

  • A retrospective analysis of 229 patients undergoing CSM and 43 undergoing the modified maze procedure during mitral valve surgery.
  • Propensity score matching (1:2 ratio) was used to compare outcomes between 43 modified maze patients and 86 CSM patients.
  • Atrial fibrillation recurrence rates at 2 years, absence of anti-arrhythmic drug use, and operative times were analyzed.

Main Results:

  • The modified maze procedure demonstrated significantly shorter aortic cross-clamp times (76.3 vs. 92.4 minutes, p<0.001).
  • No significant difference in early mortality (0% vs. 1.1%, p=0.722) or late strokes/deaths was observed between groups.
  • Both procedures showed similar rates of freedom from AF recurrence without anti-arrhythmic drugs at 2 years (p=0.332).

Conclusions:

  • The modified maze procedure simplifies the "cut-and-sew" technique and reduces operative time.
  • This approach maintains the high efficacy of CSM for eliminating persistent AF in patients undergoing mitral valve surgery.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
18
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
32
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25